Directory
Portfolio companies.
34,000+ PE-backed.
Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.
Active deals
3
currently held
Exits tracked
0
hand-checked
Sectors covered
1
across the portfolio
Countries covered
1
from every market
Latest activity
Caledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week agoCapital Event · capital-cancellation-shares · Capital structure change
capitalCaledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week agoCapital Event · capital-cancellation-shares · Capital structure change
capitalCaledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week agoCapital Event · capital-cancellation-shares · Capital structure change
capital
Elaia PartnersadminCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway2 weeks agoCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway
adminLauxera Capital PartnersadminBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board1 month agoBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board
admin3 companies matching
| Company | Sector | Geo | Investor | Entry | Hold | Status | Buyer | MOIC | |
|---|---|---|---|---|---|---|---|---|---|
Chanelle Pharma Exponent Private Equity Partners V | Exponent Private Equity | 2024 | 2yr | Active | – | – | |||
PrioThera Earlybird Health | Earlybird Venture Capital | 2020 | 6yr | Active | – | – | |||
Shorla Pharma Enterprise Ireland | Enterprise Ireland | – | – | Active | – | – |
Chanelle Pharma
Exponent Private Equity Partners V
IrelandSector
Pharma
InvestorExponent Private Equity
Entry
2024
Hold
2yr
PrioThera
Earlybird Health
IrelandSector
Pharma
InvestorEarlybird Venture Capital
Entry
2020
Hold
6yr
Shorla Pharma
Enterprise Ireland
IrelandSector
Pharma
InvestorEnterprise Ireland
Entry
–